The CRESTAR consortium

CRESTAR represents a unique mix of people with different skills all dedicated towards the better assessment and understanding of pharmacogenomics biomarkers for schizophrenia. This team is drawn from different EU member states, cultures and backgrounds but all working together towards a common goal.

The coordinator of the CRESTAR project is Prof. David Collier from King’s College London / Eli Lilly, UK.

Institution
Town
Country
Reykjavik
Iceland
Cardiff
UK
Aarhus
Denmark
Fürstenfeldbruck
Germany
Nijmegen
The Netherlands
Windlesham
UK